Sprutha Impex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.50 M
- Revenue Growth 17.92%
- Profit Growth 1.53%
- Ebitda 62.05%
- Net Worth -66.94%
- Total Assets -29.81%
About Sprutha Impex
Sprutha Impex Private Limited (SIPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 September 2018 (Six years and four months 21 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Neeta Nargundkar and Uday Nargundkar serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51909MH2018PTC314879
-
Company No.
314879
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Sep 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sprutha Impex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeta Nargundkar
|
Director | 27-Sep-2018 | Current |
|
Uday Nargundkar
|
Director | 27-Sep-2018 | Current |
Financial Performance of Sprutha Impex.
Sprutha Impex Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.92% increase. The company also saw a slight improvement in profitability, with a 1.53% increase in profit. The company's net worth observed a substantial decline by a decrease of 66.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sprutha Impex?
Unlock access to Sprutha Impex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Biosphere Clinical Research Private LimitedNeeta Nargundkar and Uday Nargundkar are mutual person
Charges (Loans)
₹0
₹2.50 M
Charges Breakdown by Lending Institutions
- Tjsb Sahakari Bank Limited : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Aug 2019 | Tjsb Sahakari Bank Limited | ₹2.50 M | Satisfied |
How Many Employees Work at Sprutha Impex?
Unlock and access historical data on people associated with Sprutha Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sprutha Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sprutha Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.